For original NDAs and BLAs (as opposed to sNDAs and sBLAs), the 6-month or 10-month review clock starts when the application is accepted by the FDA for filing—not when the application was submitted.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”